All holdings
Bruker BRKR
Source: the SEC Form 13F filings of the managers we follow, latest for Q2 2026. How we use them
Managers holding
1
In their latest 13F (Q2 2026)
See who
Value held
$53.8m
Combined value at quarter end
Last quarter
1 bought
0 sold or trimmed
Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance
Who holds it Over time Directors’ trades About the company
Managers holding it, by quarter 0 Q4 ’23
0 Q1 ’24
0 Q2 ’24
0 Q3 ’24
0 Q4 ’24
0 Q1 ’25
0 Q2 ’25
0 Q3 ’25
0 Q4 ’25
0 Q1 ’26
1 Q2 ’26
0 Q3 ’26
Q4 ’23: 0; Q1 ’24: 0; Q2 ’24: 0; Q3 ’24: 0; Q4 ’24: 0; Q1 ’25: 0; Q2 ’25: 0; Q3 ’25: 0; Q4 ’25: 0; Q1 ’26: 0; Q2 ’26: 1; Q3 ’26: 0 Counts the managers on this site whose 13F for that quarter includes Bruker.
Who holds it Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.
Download the holders: CSV · JSON · Markdown
Directors buying and selling Open-market trades by directors, officers and 10% holders over the last 12 months. How this works From their Form 4 filings with the SEC. Grants, option exercises and shares sold to pay tax are left out.
Sort by Date (high to low) Date (low to high) Who (Z–A) Who (A–Z) Shares (high to low) Shares (low to high) Value (high to low) Value (low to high) Insider purchases and sales of Bruker Date▼ Who Bought or sold Shares Price Value Filing 15 Sep 2026 Munch MarkEXEC VP&PRES BRUKER NANO INC. ▼ Sold 2,000 $52.87 $106k Form 4 17 Aug 2026 Pusch WolfgangPresident BMID Group ▼ Sold 3,473 $56.90 $198k Form 4 14 Aug 2026 Munch MarkEXEC VP&PRES BRUKER NANO INC. ▼ Sold 2,000 $57.60 $115k Form 4
About the company Sector Technology · Laboratory Analytical Instruments Incorporated in Delaware Financial year ends 31 December Shares outstanding 152m at 29 Jul 2025 SEC filings Annual reports and other filings on EDGAR Revenue and profit $1.8bn 2013
$1.6bn 2015
$1.8bn 2017
$2.1bn 2019
$2.4bn 2021
$3.0bn 2023
$3.4bn 2025
2013: $1.8bn; 2014: $1.8bn; 2015: $1.6bn; 2016: $1.6bn; 2017: $1.8bn; 2018: $1.9bn; 2019: $2.1bn; 2020: $2.0bn; 2021: $2.4bn; 2022: $2.5bn; 2023: $3.0bn; 2024: $3.4bn; 2025: $3.4bn Bruker revenue and net income by year Year Revenue Net income 2025 $3.4bn −$8.3m 2024 $3.4bn $114m 2023 $3.0bn $429m 2022 $2.5bn $299m 2021 $2.4bn $281m 2020 $2.0bn $158m 2019 $2.1bn $197m 2018 $1.9bn $180m 2017 $1.8bn $78.6m 2016 $1.6bn $154m 2015 $1.6bn $102m 2014 $1.8bn $56.7m 2013 $1.8bn $80.1m
From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.